Literature DB >> 18028342

Late-life body mass index and dementia incidence: nine-year follow-up data from the Kungsholmen Project.

Anna Rita Atti1, Katie Palmer, Stefano Volpato, Bengt Winblad, Diana De Ronchi, Laura Fratiglioni.   

Abstract

OBJECTIVES: To describe the association between late-life body mass index (BMI) and dementia development with a time perspective and to investigate the effect of weight changes on dementia incidence.
DESIGN: Three-, 6-, and 9-year follow-up study.
SETTING: The Kungsholmen Project. PARTICIPANTS: One thousand two hundred fifty-five subjects aged 75 and older with baseline BMI data available. MEASUREMENTS: Cox-regression models were used to estimate hazard ratios (HRs) for dementia detected at different risk periods in relation to baseline BMI. The association between BMI changes and development of dementia after 3 and 6 years was also analyzed.
RESULTS: Subjects with a BMI of 25.0 kg/m2 or higher had a lower risk of developing dementia than subjects with a BMI of 20.0 to 24.9 (HR=0.75, 95% confidence interval (CI)=0.59-0.96), even when cases occurring only during the last follow-up period (6-9 years after BMI assessment) were included (HR=0.66. 95% CI=0.40-1.07). Severe BMI loss (>10%) was related to a greater risk of dementia, but this association was present only for dementia cases detected in the subsequent 3 years (HR=2.18, 95% CI=1.27-3.74).
CONCLUSION: This study does not confirm that being overweight in late life is a risk factor for dementia, although a protective effect for a BMI greater than 25.0 is suggested. In addition, BMI loss is confirmed as a marker of incipient dementia. The findings suggest that, from a clinical perspective, the cognitive profile of elderly persons with unexplained weight loss should be considered and that being moderately overweight at older ages might be indicative of good health status.

Entities:  

Mesh:

Year:  2007        PMID: 18028342     DOI: 10.1111/j.1532-5415.2007.01458.x

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN: 0002-8614            Impact factor:   5.562


  91 in total

Review 1.  Can bariatric surgery reduce risk of Alzheimer's disease?

Authors:  Kelly M Stanek; John Gunstad
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2012-07-04       Impact factor: 5.067

Review 2.  Adiposity and Alzheimer's disease.

Authors:  José A Luchsinger; Deborah R Gustafson
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2009-01       Impact factor: 4.294

3.  Sex hormone binding globulin and verbal memory in older men.

Authors:  Yoichiro Takayanagi; Adam P Spira; Roger S McIntyre; William W Eaton
Journal:  Am J Geriatr Psychiatry       Date:  2013-06-22       Impact factor: 4.105

Review 4.  Neurodegenerative disease and obesity: what is the role of weight loss and bariatric interventions?

Authors:  Hutan Ashrafian; Leanne Harling; Ara Darzi; Thanos Athanasiou
Journal:  Metab Brain Dis       Date:  2013-05-08       Impact factor: 3.584

5.  Associations between Sarcopenic Obesity and Cognitive Impairment in Elderly Chinese Community-Dwelling Individuals.

Authors:  H Wang; S Hai; Y X Liu; L Cao; Y Liu; P Liu; Y Yang; B R Dong
Journal:  J Nutr Health Aging       Date:  2019       Impact factor: 4.075

6.  Linking biological and cognitive aging: toward improving characterizations of developmental time.

Authors:  Stuart W S MacDonald; Correne A DeCarlo; Roger A Dixon
Journal:  J Gerontol B Psychol Sci Soc Sci       Date:  2011-07       Impact factor: 4.077

Review 7.  Dietary omega 3 polyunsaturated fatty acids and Alzheimer's disease: interaction with apolipoprotein E genotype.

Authors:  P Barberger-Gateau; C Samieri; C Féart; M Plourde
Journal:  Curr Alzheimer Res       Date:  2011-08       Impact factor: 3.498

8.  Adiposity indicators and dementia over 32 years in Sweden.

Authors:  D R Gustafson; K Bäckman; M Waern; S Ostling; X Guo; P Zandi; M M Mielke; C Bengtsson; I Skoog
Journal:  Neurology       Date:  2009-11-10       Impact factor: 9.910

9.  Body mass index, lifestyles, physical performance and cognitive decline: the "Treviso Longeva (TRELONG)" study.

Authors:  M Gallucci; S Mazzuco; F Ongaro; E Di Giorgi; P Mecocci; M Cesari; D Albani; G L Forloni; E Durante; G B Gajo; A Zanardo; M Siculi; L Caberlotto; C Regini
Journal:  J Nutr Health Aging       Date:  2013-04       Impact factor: 4.075

Review 10.  Epidemiology of Alzheimer disease.

Authors:  Richard Mayeux; Yaakov Stern
Journal:  Cold Spring Harb Perspect Med       Date:  2012-08-01       Impact factor: 6.915

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.